Cancer Gene Therapy

Papers
(The H4-Index of Cancer Gene Therapy is 24. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)
ArticleCitations
PCA3 controls chromatin organization and p53 signal activation by regulating LAP2α-lamin A complexes237
Serum small extracellular vesicles-derived BST2 as a biomarker for papillary thyroid microcarcinoma promotes lymph node metastasis183
Retraction Note: Circular RNA hsa_circ_0009172 suppresses gastric cancer by regulation of microRNA-485-3p-mediated NTRK389
Oncolytic virus encoding 4-1BBL and IL15 enhances the efficacy of tumor-infiltrating lymphocyte adoptive therapy in HCC73
RETRACTED ARTICLE: Targeting KDM1B-dependent miR-215-AR-AGR2-axis promotes sensitivity to enzalutamide-resistant prostate cancer57
RETRACTED ARTICLE: CREB3L4 promotes angiogenesis and tumor progression in gastric cancer through regulating VEGFA expression53
Reviewer Recognition52
Proteomic time course of breast cancer cells highlights enhanced sensitivity to Stat3 and Src inhibitors prior to endocrine resistance development50
Cannabinoids orchestrate cross-talk between cancer cells and endothelial cells in colorectal cancer49
HPV status represents dominant trait driving delineation of survival-associated gene co-expression networks in head and neck cancer47
An alternative fully human anti-BCMA CAR-T shows response for relapsed or refractory multiple myeloma with anti-BCMA CAR-T exposures previously41
Alternative splicing events in tumor immune infiltration in renal clear cell carcinomas40
Modification of the tumor microenvironment enhances immunity with plasmid gene therapy34
Long noncoding RNA LINC00173 induces radioresistance in nasopharyngeal carcinoma via inhibiting CHK2/P53 pathway33
Pan-cancer methylome analysis for cancer diagnosis and classification of cancer cell of origin30
Therapeutic applications of local injection of hsa-miR-634 into canine spontaneous malignant melanoma tumors30
NCBP2 and TFRC are novel prognostic biomarkers in oral squamous cell carcinoma29
SIX3 function in cancer: progression and comprehensive analysis28
Key chemokines direct migration of immune cells in solid tumors28
Reducing the risks of nuclear war—the role of health professionals28
Use of CRISPR-based screens to identify mechanisms of chemotherapy resistance26
GLIPR1 promotes proliferation, metastasis and 5-fluorouracil resistance in hepatocellular carcinoma by activating the PI3K/PDK1/ROCK1 pathway26
Gut microbiota-mediated activation of GSDMD ignites colorectal tumorigenesis24
Inhibition of the galactosyltransferase C1GALT1 reduces osteosarcoma cell proliferation by interfering with ERK signaling and cell cycle progression24
0.12754201889038